Tamin Pharmaceutical Investment Company (TPICO) with 27 active companies has been present in all areas of the supply chain of drugs and pharmaceutical supplements (production of raw materials and products, distribution and trading) since 2012 and is the largest pharmaceutical holding in the country. Having the largest drug production factories and having a wide portfolio of products, TPICO is the largest domestic supplier, and also in the field of exporting drugs and raw materials to more than 40 countries, innovative activities in the field of research and development and in the field of commerce, it is known as the most effective pharmaceutical company in the country with international reputable agencies.
Tamin Pharmaceutical Investment Company (TPICO) is the largest pharmaceutical holding company in Iran, which has been operating since 1992 and is the largest Iranian exporter of pharmaceutical products. Companies in TPICO are working with an innovative approach and using the latest global knowledge and technology therewith valuable human resource to provide high quality and affordable medications for people. TPICO’s mission is “Optimal management of the investment portfolio in pharmaceutical industry with the aim of creating value for shareholders and providing high quality and affordable medications for society/ patients.” TPICO’s vision is to be “The top pharmaceutical holding in the country’s capital market in terms of managing the Return of Assets”. In addition to fulfilling its social responsibilities, TPICO is committed to protect the assets of millions of Social Security Insured people who are the real owners of these companies.
Pharmaceutical Research and Development
Research and Development units of TPICO companies are among the most active units in the development of raw materials and new pharmaceutical finished products in the country. While developing new products required by the country’s pharmaceutical market, they are also responsible for optimizing production process in the companies.
Production of Pharmaceutical Raw Material (APIs)
With the backbone of its most valuable capital, i.e. experienced human resources, TPICO companies are producing a great share of Active Pharmaceutical Ingredient (APIs) needed in Pharma Industry in Iran and exports some products overseas as well.
Production of the final product
TPICO has 9 factories producing human pharmaceutical products with more than 800 products in different therapeutic categories. Some of these products are produced exclusively in our manufacturing plants for domestic market.
Country distribution
TPICO Holding, with 3 human pharmaceutical distribution companies and one dedicated veterinary
medicines distribution company holds nearly 40% of market share in Iran and is the principal pharmaceutical distributor in the country.
Commerce and services
As a TPICO owned company, Owzan is among the most reputable trading companies in medical device market in Iran. Owzan Co. is a very successful company to supply the needs of medical centers and hospitals in the country enjoying partnership with many reputable companies around the world. Further to medical devices, Owzan company also imports some essential medicines and raw materials needed by pharma industry.
DRUGs-list
